| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 8 Aug 2025 | 28 Jul 2025 |
| Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve Board Meeting Intimation scheduled to be held on Friday 08th August 2025. Appointment of Additional Director (Executive Director)- The Company has informed the appointment of Mr. Pankaj Kumar Gupta as Additional Director with effect from 08th August, 2025. (As per BSE Announcement Dated on 08.08.2025) | ||
| Board Meeting | 6 May 2025 | 29 Apr 2025 |
| Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 inter alia to consider and approve The Company has informed the Exchange about the Board Meeting scheduled to be held on 06th May 2025 for the purpose of approving the Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March 2025 and also Final Dividend for the Financial Year ended 31st March 2025. Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 06th May, 2025, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020, approved the following businesses: a. Audited Financial Results (Consolidate & Standalone) for the Fourth quarter and financial year ended on 31st March 2025. b. Recommendation of Dividend of Rs. 3.50 (Three and half Rupees) per Equity Shares (70%) of Rs. 5 each for the Financial Year 2024-25, subject to the approval of shareholders. c. Appointment of Mr. Vishal Baid, DIN: 00232727 as an Executive Director on board subject to shareholders approval in ensuing General Meeting. d. Mrs. Mukulika Baid, Non Executive Non Independent Director Step Down from the Directorship of the Company. e. Appointment of Auditor(s) (As per BSE Announcement Dated on 06/05/2025) | ||
| Board Meeting | 3 Feb 2025 | 27 Jan 2025 |
| POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve The Company informed the Exchange about the Board Meeting to be held on 03rd February 2025. Pursuant to the Regulation 30 of SEBI(LODR) Regulations, 2015, Company has informed about the outcome of the Board Meeting held on today i.e. 03rd February, 2025. The Company has informed about the Unaudited Financial Results ( Standalone & Consolidated ) for the Third quarter and nine months ended on 31st December, 2024 (As per BSE Announcement Dated on 03/02/2025) | ||
| Board Meeting | 28 Oct 2024 | 19 Oct 2024 |
| POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve The Company informed the Exchange about the upcoming Board Meeting Scheduled to be held on 28th October 2024 The Company has informed the exchange about the outcome of the Board Meeting held on today i.e. 28th October, 2024. (As Per BSE Announcement dated on 28.10.2024) | ||
Here are some of the stocks that may see significant price movement today; Bajaj Auto, Zomato, Nucleus Software, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
